Medical devices, healthcare technology and the business of care
PMA approval · P030045

INTRASTENT DOUBLESTRUT STENT

Medtronic Vascular, Inc. · Decision date Jun 8, 2004

MEDTECHLEDGER EXPLANATIONP030045

What did the FDA approve?

The FDA database records a 2004 approval for the IntraStent DoubleStrut Stent from Medtronic Vascular, Inc. The stated purpose is improving luminal diameter in patients with symptomatic atherosclerotic disease of the common and/or external iliac arteries up to 100 mm in length, with a reference vessel diameter of 5 to 10 mm.

The record identifies the device category as an iliac stent under product code NIO. The source statement reports the approved indication but does not include clinical data, safety outcomes, or effectiveness evidence. No supplement type or reason is listed, so this entry reflects the original approval scope rather than a change to it.

FDA approval order statement

APPROVAL FOR THE INTRASTENT DOUBLESTRUT STENT. THE DEVICE IS INDICATED FOR IMPROVING LUMINAL DIAMETER IN PATIENTS WITH SYMPTOMATIC ATHEROSCLEROTIC DISEASE OF THE COMMON AND/OR EXTERNAL ILIAC ARTERIES UP TO 100 MM IN LENGTH, WITH A REFERENCE VESSEL DIAMETER OF 5 TO 10 MM.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jun 8, 2004

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P030045
Regulatory pathway
Premarket approval application
Product code
NIO
Decision code
APPR
Decision date
Jun 8, 2004
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Product code
NIO
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P030045 received

    Application receipt date recorded by FDA.

  2. P030045 · FDA decision

    APPR

  3. P030045/S011 · Related supplement

    Visi-Pro balloon-Expandable peripheral stent system

Timeline entries are records held by MedtechLedger for P030045. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030045

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA
Cordis US CorporationPMA supplementOct 15, 2026FDA
Biotronik AGPMA supplementSep 11, 2026FDA
Biotronik AGPMA approvalDec 17, 2015FDA
Cook Ireland, Ltd.PMA approvalJun 26, 2006FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records